Status:
COMPLETED
Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.
Lead Sponsor:
Technische Universität Dresden
Conditions:
Healthy Subjects
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.
Eligibility Criteria
Inclusion
- healthy subjects
Exclusion
- any relevant disease
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00180024
Start Date
January 1 2002
End Date
September 1 2005
Last Update
September 16 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Clinical Pharmacology, Medical Faculty, University of Technology
Dresden, Germany, 01307